Form 4: EXAS CFO Aaron Bloomer Reports RSU Vesting, Tax Withholding

Exact Sciences CFO Aaron Bloomer reported the vesting of restricted stock units and subsequent tax-related share disposals, with some vesting accelerated due to Section 280G Mitigation.

Summary

• Aaron Bloomer, EVP, Chief Financial Officer of Exact Sciences Corp (EXAS), reported changes in beneficial ownership on December 23, 2025.
• Bloomer acquired 38,715 shares of common stock upon the vesting of a restricted stock unit (RSU) award.
• An additional 24,384 shares of common stock were acquired from another RSU award vesting on the same date.
• In connection with these vestings, 17,151 shares and 10,803 shares were disposed of by Exact Sciences Corporation for tax withholding purposes at a price of $101.82 per share.
• The vesting of portions of these RSU awards was accelerated in connection with "Section 280G Mitigation."
• Following these transactions, Bloomer directly owns 48,768 shares of common stock and indirectly owns 212 shares in a 401(k) Plan, totaling 48,980 shares.
• Bloomer also holds an aggregate of 4,395 unvested restricted stock units.

Sentiment

Score: 5

Explanation: This Form 4 reports routine executive compensation events (RSU vesting and tax withholding). The acceleration of vesting due to "Section 280G Mitigation" is a notable detail that could imply a corporate event, but the filing itself does not provide enough information to assess its positive or negative impact, thus maintaining a neutral sentiment.

Positives

• The vesting of restricted stock units indicates continued executive incentive and alignment with shareholder interests.
• The executive's beneficial ownership of common stock remains substantial, demonstrating a vested interest in the company's performance.

Negatives

• The disposition of shares for tax withholding purposes reduces the executive's direct shareholding, which is a standard practice for RSU vesting.
• The acceleration of RSU vesting due to "Section 280G Mitigation" could imply a significant corporate event (e.g., change of control) that might warrant further investigation, though the filing itself does not provide details on the nature or implications of this mitigation.

Risks

• The filing does not explicitly mention specific risks. However, the reference to "Section 280G Mitigation" could be a signal of potential corporate events (e.g., mergers, acquisitions, or other change-in-control scenarios) that inherently carry risks, though the Form 4 itself does not detail these.

Future Outlook

This Form 4 filing does not contain forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This Form 4 filing reports an individual executive's compensation-related transactions and does not provide broader industry context or trends.

Stakeholder Impact

• Shareholders: Provides transparency on executive compensation and ownership changes. The acceleration of RSU vesting due to "Section 280G Mitigation" might signal potential corporate actions that could impact shareholder value, though the filing does not elaborate.
• Management: Reflects a portion of the CFO's compensation structure and beneficial ownership.

Next Steps

• The reporting person's remaining 4,395 unvested restricted stock units are subject to continued service through their respective vesting dates.

Key Dates

Keywords

EXAS, Exact Sciences, Form 4, Insider Transaction, RSU Vesting, Executive Compensation, Aaron Bloomer, CFO, Beneficial Ownership